Decreased expression of annexin A1 during the progression of cervical neoplasia

Journal of International Medical Research

Volumn 36, Issue 4, 2008, Pages 665-672

  Wang, L D ^a   Yang, Y H ^b   Liu, Y ^a   Song, H T ^a   Zhang, L Y ^a   Li, P L ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Annexin A1; Cervical intraepithelial neoplasia; Differentiation; Squamous cell carcinoma of the cervix

Indexed keywords

LIPOCORTIN 1; PARAFFIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; ANIMAL; CYTOLOGY; DISEASE COURSE; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ANIMALS; ANNEXIN A1; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 52049092280     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600407     Document Type: Article

References (30)

1. Sankaranarayanan R, Budukh AM, Rajkumar R: Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001; 79: 954-962.
2. Creasman WJ: Preinvasive disease of the cervix. In: Clinical Gynecologic Oncology, 6th edn (DiSaia PJ, Creasman WJ, eds). St Louis: Mosby, 2002; pp 1-34.
3. Richart RM: A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990; 75: 131-133.
4. Bosch FX, Lorincz A, Munoz N, et al: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
5. Kjellberg L, Hallmans G, Ahren AM, et al: Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papilloma virus infection. Br J Cancer 2000; 82: 1332-1338.
6. Gerke V, Moss SE: Annexins: from structure to function. Physiol Rev 2002; 82: 331-371.
7. Dreier R, Schmid KW, Gerke V, et al.: Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol 1998; 110: 137-148.
8. Flower RJ, Rothwell NJ: Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994; 15: 71-76.
9. Croxtall JD, Flower RJ: Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci USA 1992; 89: 3571-3575.
10. Violette SM, King I, Browning JL, et al: Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol 1990; 142: 70-77.
11. Diakonova M, Gerke V, Ernst J, et al: Localization of five annexins in J774 macrophages and isolated phagosomes. J Cell Sci 1997; 110: 1199-1213.
12. Wallner BP, Mattalliano RJ, Hession C, et al: Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 1986; 320: 77-81.
13. Masaki T, Tokuda M, Ohnishi M, et al: Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24: 72-81.
14. Wang KL, Wu TT, Resetkova E, et al: Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006; 12: 4598-4604.
15. Falini B, Tiacci E, Liso A, et al: Simple diagnostic assay for hairy cell leukaemia by immunohistochemical detection of annexin A1 (ANXA1) Lancet 2004; 363: 1869-1870.
16. Hu N, Flaig MJ, Su H, et al: Comprehensive characterization of annexin 1 alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 6013-6022.
17. Kang JS, Calvo BF, Maygarden SJ, et al: Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002; 8: 117-123.
18. Garcia Pedrero JM, Fernandez MP, Morgan RO, et al: Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004; 164: 73-79.
19. Ahn SH, Sawada H, Ro JY, et al: Differential expression of annexin 1 in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metatasis 1997; 15: 151-156.
20. Shen D, Nooraie F, Elshimali Y, et al: Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006; 37: 1583-1591.
21. Croxtall JD, Waheed S, Choudhury Q, et al: N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer 1993; 54: 153-158.
22. Hsiang CH, Tunoda T, Whang YE, et al: The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006; 66: 1413-1424.
23. Alldridge LC, Bryant CE: Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003; 290: 93-107.
24. Cheung TH, Yu MM, Lo KW, et al: Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 2001; 166: 199-206.
25. Pepinsky RB, Sinclair LK: Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986; 321: 81-84.
26. Kersemaekers AM, Fleuren GJ, Kenter GG, et al: Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 1999; 5: 577-586.
27. Rodrigues-Lisoni FC, Mehet DK, Peitl P, et al: In vitro and in vivo studies on CCR10 regulation by Annexin A1. FEBS Lett 2006; 580: 1431-1438.
28. Solito E, de Coupade C, Parente L, et al: Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ 1998, 9: 327-336.
29. Fang Y, Guan X, Guo Y, et al: Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 2001; 30: 254-260.
30. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427-5440.